Chronic Kidney Disease Market in India

Chronic Kidney Disease in India Trends and Forecast

The future of the chronic kidney disease market in India looks promising with opportunities in the hospital and dialysis center markets. The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2031 with a CAGR of 6.5% from 2025 to 2031. The chronic kidney disease market in India is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising occurrence of CKD and the usage of technologically advanced products and diagnostic tests.

• Lucintel forecasts that, within the treatment category, drugs are expected to witness a higher growth over the forecast period due to the introduction of new drugs and therapies to help healthcare professionals treat patients effectively.
• Within the end use category, hospitals are expected to witness a higher growth as it is equipped with advanced facilities, which are required to treat and manage CKD.

Emerging Trends in the Chronic Kidney Disease Market in India

Chronic Kidney Disease is becoming an increasingly significant health concern in India due to rising levels of diabetes, hypertension, and an aging population. The demand for chronic kidney disease-related treatments is growing, and several emerging trends are shaping the healthcare landscape. These trends reflect India’s efforts to improve awareness, increase access to care, and incorporate technological advancements into the management of chronic kidney disease. These trends not only enhance patient outcomes but also aim to make kidney disease care more accessible and cost-effective across the country.

• Increasing Focus on Early Diagnosis and Screening: Early diagnosis of chronic kidney disease through mass screening campaigns, especially targeting high-risk groups like individuals with diabetes and hypertension, is emerging as a key trend in India. Government and private healthcare sectors are launching awareness programs and screening initiatives to detect kidney disease before it reaches an advanced stage. Early detection enables better disease management and reduces the cost burden of more invasive treatments, helping in the prevention of kidney failure.
• Adoption of Telemedicine for chronic kidney disease Care: With rapid technological advancements, telemedicine is becoming an essential tool for chronic kidney disease management in India, especially in rural and underserved regions. Remote consultation platforms enable nephrologists to provide personalized care, offer guidance on dialysis, and monitor patient progress from a distance. Telemedicine helps overcome geographic barriers, ensuring that even people in remote areas have access to specialized care, improving patient outcomes, and reducing travel expenses.
• Growth in Home Dialysis and Patient-Centric Care: Home dialysis, including both peritoneal dialysis (PD) and home hemodialysis (HD), is gaining traction in India. Patients are increasingly opting for these treatments to maintain their independence and avoid frequent hospital visits. Technological improvements in dialysis machines and the availability of training programs for patients are making home dialysis a viable option. This trend is shifting chronic kidney disease care toward more patient-centered solutions, reducing strain on hospitals and improving patients quality of life.
• Increased Availability of Generic Drugs for Chronic Kidney Disease Treatment: The availability of affordable generic drugs is reshaping chronic kidney disease management in India, where healthcare costs can be prohibitive. Generic medications for managing hypertension, diabetes, and kidney function are now more widely available, enabling patients to adhere to prescribed regimens without incurring high out-of-pocket expenses. This trend is crucial for ensuring that more people can afford life-saving medications, especially in low- and middle-income households.
• Innovative Dialysis Technologies and Treatments: Advancements in dialysis technology, such as the development of wearable artificial kidneys, are making chronic kidney disease treatments more efficient, convenient, and less invasive. These technologies aim to improve the quality of life for dialysis patients by offering more mobility and reducing the need for frequent clinic visits. In addition, the rise of innovative treatments, such as stem cell therapy and regenerative medicine, offers hope for better kidney disease management and even potential cures in the future.

These emerging trends in India, from early diagnosis and telemedicine adoption to home dialysis and the use of generic drugs, are significantly reshaping the chronic kidney disease market. By increasing accessibility to care, reducing treatment costs, and incorporating technological innovations, India is progressing toward a more efficient and patient-centered approach to chronic kidney disease management, improving long-term outcomes for patients.

Recent Developments in the Chronic Kidney Disease Market in India

The chronic kidney disease market in India is evolving rapidly, driven by advancements in medical technology, policy changes, and growing healthcare access. Key recent developments reflect India’s commitment to improving chronic kidney disease care, including innovations in dialysis options, increased awareness, and expanded access to treatment. These developments are not only enhancing patient outcomes but also ensuring that care is more accessible, timely, and affordable for the growing chronic kidney disease population in the country.

• Expansion of Dialysis Centers Across India: India has seen a significant rise in the number of dialysis centers, especially in tier-II and tier-III cities, where access to treatment was previously limited. The government’s push for expanding healthcare infrastructure and private investment in dialysis services is improving patient access. As a result, patients can receive timely and affordable dialysis care, preventing delays in treatment that can lead to severe complications.
• Introduction of Cost-Effective Dialysis Machines: The development and introduction of cost-effective dialysis machines in India have greatly increased the availability of dialysis treatment. Companies are now offering affordable, portable, and user-friendly dialysis equipment, particularly in rural and underserved areas. This is especially important in a country where financial barriers often prevent timely and adequate care for chronic kidney disease patients.
• Government Support for Chronic Kidney Disease Awareness Campaigns: The Indian government has launched several initiatives aimed at increasing awareness about chronic kidney disease, including campaigns focused on preventing diabetes and hypertension, the primary risk factors for kidney disease. These campaigns have played a vital role in educating the public about chronic kidney disease prevention, early diagnosis, and the importance of lifestyle modifications, leading to more early-stage diagnoses and better health outcomes.
• Affordable Kidney Transplantation: In response to the growing demand for kidney transplants, India has made significant progress in improving transplant services. Increased government funding and the growth of the organ donation network have led to higher transplant success rates. Additionally, the costs associated with kidney transplantation are becoming more manageable due to the availability of more affordable treatment options and a growing number of transplant centers.
• Collaboration Between Government and Private Sector: Recent partnerships between the Indian government and private healthcare providers have enhanced the reach and quality of chronic kidney disease care. These collaborations focus on reducing the financial burden on patients, improving infrastructure, and integrating cutting-edge treatments. Public-private partnerships have proven effective in scaling up dialysis services, improving early diagnosis, and enabling better patient care across the country.

Recent developments in India’s chronic kidney disease market, including the expansion of dialysis centers, government awareness campaigns, and improved access to transplantation services, are making significant strides in addressing the growing burden of kidney disease. These developments are improving access to care, reducing treatment costs, and ultimately helping to enhance the quality of life for chronic kidney disease patients across India.

Strategic Growth Opportunities for Chronic Kidney Disease Market in India

As the prevalence of chronic kidney disease rises in India, new growth opportunities are emerging across various sectors, including diagnostic tools, treatment options, and patient education. Addressing the increasing demand for chronic kidney disease care presents significant opportunities for businesses and healthcare providers to invest in innovative solutions. By focusing on key applications, India can tackle the rising healthcare burden while improving patient outcomes.

• Telemedicine and Remote Monitoring Solutions: The growing demand for telemedicine services presents a significant growth opportunity in the chronic kidney disease market. Remote monitoring tools for kidney function, coupled with virtual consultations with nephrologists, can provide better management of chronic kidney disease, particularly in rural areas where access to healthcare professionals is limited. This trend not only improves access to specialized care but also enables continuous monitoring and early intervention, preventing disease progression.
• Expansion of Home Dialysis Solutions: The demand for home dialysis treatments, including peritoneal dialysis (PD) and home hemodialysis (HD), is expected to increase in India as more patients seek flexible and less invasive treatment options. By developing affordable, user-friendly dialysis machines and providing comprehensive patient education programs, healthcare providers can support patients in managing their disease at home, improving treatment adherence and quality of life.
• Artificial Intelligence (AI) and Data Analytics in chronic kidney disease: The integration of AI and data analytics into chronic kidney disease care offers opportunities for improving diagnosis, treatment, and patient monitoring. AI-driven tools can analyze patient data to predict disease progression, customize treatment plans, and identify potential complications early. This technology-driven approach is expected to revolutionize chronic kidney disease care, enabling more personalized, efficient, and accurate management.
• Increasing Demand for Affordable Generic Medications: The rising burden of chronic kidney disease calls for affordable and accessible medications to manage the disease. The growth of generic drugs for controlling diabetes, hypertension, and kidney function provides a substantial opportunity in the Indian market. Pharmaceutical companies focusing on the production and distribution of high-quality generic medications can help reduce the financial burden on chronic kidney disease patients while ensuring better medication adherence.
• Public-Private Partnerships for Kidney Care Infrastructure: The collaboration between the government and private healthcare providers presents an opportunity for scaling up kidney disease prevention and treatment programs. Public-private partnerships can drive investments in dialysis centers, transplant services, and diagnostic tools. By improving infrastructure and reducing costs, these partnerships can increase access to care and improve overall patient outcomes, particularly in underserved regions.

The strategic growth opportunities in India’s chronic kidney disease market, such as telemedicine, home dialysis, AI integration, affordable medications, and public-private partnerships, are poised to reshape kidney disease care. By focusing on these areas, India can effectively manage the growing chronic kidney disease burden, improve patient outcomes, and increase access to high-quality treatment for a larger population.

Chronic Kidney Disease Market in India Driver and Challenges

The chronic kidney disease market in India is influenced by a range of drivers and challenges. Factors like an aging population, rising rates of diabetes and hypertension, and advancements in medical technology are accelerating the demand for chronic kidney disease treatments. However, challenges such as limited access to care, high treatment costs, and a shortage of kidney donors pose significant barriers. Understanding these drivers and challenges is crucial to addressing the growing chronic kidney disease burden in India.

The factors responsible for driving the chronic kidney disease market in India include:
• Increase in Non-Communicable Diseases (NCDs): The rise in NCDs such as diabetes and hypertension, which are primary risk factors for chronic kidney disease, is driving the demand for chronic kidney disease treatment in India. As more people develop these conditions, the need for early diagnosis, preventive measures, and specialized care is growing.
• Government Initiatives and Funding: The Indian government has increased its focus on healthcare funding for chronic kidney disease prevention, early diagnosis, and treatment. Public health campaigns and screening programs are helping identify high-risk individuals and provide access to care, contributing to improved patient outcomes and a reduction in chronic kidney disease-related mortality.
• Technological Advancements in Dialysis and Treatment: The introduction of more efficient and affordable dialysis machines, as well as innovations like home dialysis and AI-powered predictive tools, is making chronic kidney disease care more accessible and convenient for patients. These technological advancements are enhancing treatment outcomes and improving patients quality of life.
• Growing Awareness and Education: Increasing awareness about chronic kidney disease and its risk factors is leading to earlier detection and better management. Public and private healthcare organizations are investing in education campaigns to inform people about lifestyle changes, the importance of early testing, and the need for regular monitoring, which helps reduce the disease burden.
• Improvement in Organ Transplant Networks: The development of better organ transplant networks, including improvements in organ donation systems and donor registries, is a significant driver. A growing number of kidney transplants are improving outcomes for patients with end-stage renal disease (ESRD), while reducing the need for long-term dialysis treatments.

Challenges in the chronic kidney disease market in India are:
• Limited Access to Specialized Care: While urban areas are well-equipped with dialysis centers and nephrologists, rural regions in India lack adequate healthcare infrastructure. The shortage of skilled healthcare professionals and dialysis facilities in these areas limits access to care for a significant portion of the population.
• High Treatment Costs: Although healthcare services in India are generally more affordable than in many other countries, the costs of dialysis and kidney transplants can still be prohibitively expensive for many patients. This financial barrier prevents timely access to life-saving treatments, especially for the lower-income population.
• Organ Donation Shortage: Despite government initiatives, the shortage of organ donors continues to be a significant challenge. The low organ donation rate in India, combined with high demand, results in long waiting lists for kidney transplants, further complicating chronic kidney disease management.

The chronic kidney disease market in India is being shaped by several key drivers such as the increasing prevalence of NCDs, technological advancements, and government efforts. However, challenges like limited access to care, high treatment costs, and organ donation shortages remain critical hurdles. Addressing these issues through policy reforms, investment in infrastructure, and public awareness can help India tackle the growing chronic kidney disease burden effectively.

List of Chronic Kidney Disease Market in India Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, chronic kidney disease companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic kidney disease companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10

Chronic Kidney Disease Market in India by Segment

The study includes a forecast for the chronic kidney disease market in India by treatment and end use.

Chronic Kidney Disease Market in India by Treatment [Analysis by Value from 2019 to 2031]:

• Drugs
• Dialysis

Chronic Kidney Disease Market in India by End Use [Analysis by Value from 2019 to 2031]:

• Hospital
• Dialysis Center
• Others

Features of the Chronic Kidney Disease Market in India

Market Size Estimates: Chronic kidney disease in India market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Chronic kidney disease in India market size by treatment and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different treatment and end use for the chronic kidney disease in India.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic kidney disease in India.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What are the major drivers influencing the growth of the chronic kidney disease market in India?
Answer: The major drivers for this market are the rising occurrence of CKD and the usage of technologically advanced products and diagnostic tests.
Q2. What are the major segments for chronic kidney disease market in India?
Answer: The future of the chronic kidney disease market in India looks promising with opportunities in the hospital and dialysis center markets.
Q3. Which chronic kidney disease market segment in India will be the largest in future?
Answer: Lucintel forecasts that drugs are expected to witness a higher growth over the forecast period due to the introduction of new drugs and therapies to help healthcare professionals treat patients effectively.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 10 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the chronic kidney disease market in India by treatment (drugs and dialysis), and end use (hospital, dialysis center, and others)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Chronic Kidney Disease Market in India, Chronic Kidney Disease Market in India Size, Chronic Kidney Disease Market in India Growth, Chronic Kidney Disease Market in India Analysis, Chronic Kidney Disease Market in India Report, Chronic Kidney Disease Market in India Share, Chronic Kidney Disease Market in India Trends, Chronic Kidney Disease Market in India Forecast, Chronic Kidney Disease Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.